Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.89 - $15.04 $304,191 - $329,376
-21,900 Reduced 46.3%
25,400 $352,000
Q4 2023

Feb 14, 2024

SELL
$13.36 - $15.43 $1.51 Million - $1.74 Million
-112,800 Reduced 70.46%
47,300 $674,000
Q3 2023

Nov 14, 2023

SELL
$15.03 - $16.32 $1.84 Million - $1.99 Million
-122,200 Reduced 43.29%
160,100 $2.48 Million
Q2 2023

Aug 14, 2023

BUY
$15.57 - $17.11 $599,445 - $658,735
38,500 Added 15.79%
282,300 $4.43 Million
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $976,392 - $1.05 Million
63,900 Added 35.52%
243,800 $4.02 Million
Q4 2022

Feb 14, 2023

SELL
$12.42 - $15.62 $116,748 - $146,828
-9,400 Reduced 4.97%
179,900 $2.81 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $2.3 Million - $5.14 Million
179,300 Added 1793.0%
189,300 $2.46 Million
Q2 2022

Aug 08, 2022

SELL
$13.12 - $15.03 $439,520 - $503,505
-33,500 Reduced 77.01%
10,000 $140,000
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $100,196 - $113,590
-7,400 Reduced 14.54%
43,500 $623,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $285,789 - $355,879
-21,700 Reduced 29.89%
50,900 $694,000
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $1.06 Million - $1.12 Million
64,800 Added 830.77%
72,600 $1.19 Million
Q1 2021

May 17, 2021

BUY
$16.71 - $19.9 $1,671 - $1,989
100 Added 1.3%
7,800 $142,000
Q4 2020

Feb 16, 2021

BUY
$15.39 - $18.97 $118,503 - $146,069
7,700 New
7,700 $140,000
Q1 2020

May 15, 2020

SELL
$13.02 - $20.31 $6.3 Million - $9.83 Million
-484,145 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$16.15 - $17.99 $9.27 Million - $10.3 Million
-574,023 Reduced 54.25%
484,145 $8.33 Million
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $2.08 Million - $2.57 Million
-125,594 Reduced 10.61%
1,058,168 $18.7 Million
Q1 2019

May 15, 2019

BUY
$16.7 - $21.52 $19.8 Million - $25.5 Million
1,183,762 New
1,183,762 $24.1 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.